相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adoptive immunotherapy for cancer: the next generation of gene-engineered immune cells
L. J. Berry et al.
TISSUE ANTIGENS (2009)
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
C. Gravalos et al.
ANNALS OF ONCOLOGY (2008)
Phage display of chelating recombinant antibody libraries
Michael J. Wright et al.
MOLECULAR IMMUNOLOGY (2007)
Antibody constructs in cancer therapy - Protein engineering strategies to improve exposure in solid tumors
Robert A. Beckman et al.
CANCER (2007)
Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer
Ana M. Gonzalez-Angulo et al.
ONCOLOGIST (2006)
Gene expression and function study of fusion immunotoxin anti-Her-2-scFv -: SEC2 in Escherichia coli
MK Xu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2006)
A trimeric anti-HER2/neu ScFv and tumor necrosis factor-α fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia
TH Huang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Genotoxicity of retroviral integration in hematopoietic cells
Arthur W. Nienhuis et al.
MOLECULAR THERAPY (2006)
Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer
CH Yeon et al.
INVESTIGATIONAL NEW DRUGS (2005)
A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2
M Biburger et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Specific targeting of CD33+ leukemia cells by a natural killer cell line modified with a chimeric receptor
T Schirrmann et al.
LEUKEMIA RESEARCH (2005)
Overexpression of ErbB2 in cancer and ErbB2-targeting strategies
DH Yu et al.
ONCOGENE (2000)
分享论文
